Our provider-guided plans help clients from Calabasas, Pacific Palisades, and Malibu manage weight, improve metabolic health and support long-term wellness through personalized care
Medicaid, the government program that covers 69 million Americans, covers GLP-1s for medically accepted conditions like diabetes, but only about a dozen state Medicaid programs cover GLP-1s for obesity treatment, according to KFF
Acta Obstetricia et Gynecologica Scandinavica , 104(2), pp.258266
10.3390/biom14060697 11 ArabshomaliA.BazzazzadehganS.MahdiF.Shariat-MadarZ
Fractyls release highlighted an exploratory analysis of patients who achieved above-median weight loss during GLP-1 run-in, showing that Revita-treated participants experienced 4.2% weight regain versus 13.3% with sham at six months
UK laboratories and research teams purchasing MOTS-c peptide typically investigate: Metabolic homeostasis and AMPK-dependent energy signalling Insulin resistance and glucose metabolism in T1D, T2D, and obesity models Age-related muscle decline (sarcopenia) and exercise physiology Mitochondrial biogenesis and mitochondrial-nuclear communication Cellular stress response and oxidative stress adaptation Cardiac energy metabolism and diabetic cardiomyopathy models Pancreatic islet function and beta-cell senescence Liver steatosis, NASH, and metabolic-associated fatty liver disease Comparative mitochondrial peptide studies alongside Humanin and SS-31 Longevity pathway and healthspan investigations MOTS-c vs Other Mitochondrial Peptides Many researchers combine MOTS-c with other mitochondrial peptides for multi-pathway comparative studies
